Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults

Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years

NCT00616928 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)

NCT00979407 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes

NCT00992511 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)

NCT00989612 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.

NCT00714285 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

NCT01008956 ·Status: WITHDRAWN ·Phase: PHASE2

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

NCT00753272 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age

NCT01999842 ·Status: COMPLETED ·Phase: PHASE1

A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults

NCT00920374 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate an Influenza Vaccine Candidate

NCT00540228 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

NCT07121192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults

NCT01144299 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children

NCT01196988 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People

NCT00992784 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity Study of the Influenza Vaccine in Adults

NCT00258934 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT05823974 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

NCT00529516 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route)

NCT01121822 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of GSK Biologicals' FluLaval® TF

NCT00727428 ·Status: COMPLETED ·Phase: PHASE1

A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above

NCT01607112 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults

NCT01196975 ·Status: COMPLETED ·Phase: PHASE3

Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

NCT00979602 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

NCT00374842 ·Status: COMPLETED ·Phase: PHASE2

Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom

NCT00996853 ·Status: COMPLETED

Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

NCT00538473 ·Status: COMPLETED ·Phase: PHASE2